NOVEL RISK RATIO IN DIABETES AND ITS ASSOCIATED COMPLICATION Authors: Elango KS , BANU N AND VIJAYALAKSHMI S
ABSTRACT
Objective: Diabetes blood sugar level fluctuates in chronic anti-diabetic medication.
Furthermore, lipid assay value is higher, assessing the risk factor to prevent complications in
diabetes and its associated diseases difficult. Previous studies confirm the association
between lipid and insulin sensitivity. However, the compound effect of blood glucose, highdensity lipoprotein ratio versus cholesterol, blood glucose ratio has not been assessed so far
in insulin-resistant non-insulin-dependent diabetes. The present study aimed at calculating the
novel ratio, Fasting blood sugar/High-density lipoprotein (FBS/HDL) ratio versus
Cholesterol/Fasting blood sugar (CHO/FBS) ratio and investigating the correlation to
Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), and Triglyceride-glucose
(TyG) index in type 2 diabetes insulin-resistant patients.
Methods: The study includes 30 Type 2 Diabetic patients and 20 Non-diabetics (control).
Fasting serum samples used to measure Insulin, Cholesterol, Triglyceride, HDL. A fasting
plasma sample utilized to measure Plasma glucose. Results: The Fasting blood sugar/ High-density lipoprotein ratio (FBS/HDL), HOMA-IR,
TyG index and the Cholesterol/Fasting blood sugar ratio (CHOLESTEROL/FBS) between
Non-diabetic and Diabetic at a significance of p-value < 0.001 level. Serum insulin level
showed a significant difference between Non-diabetic and Diabetic at p-value < 0.05 level.
The Receiver operating characteristic curve (ROC) explains the FBS/HDL ratio and
CHOLESTEROL/FBS ratio with the good value of area under the curve by 0.907 and 0.935.
Conclusion: The FBS/HDL ratio versus CHOLESTEROL/FBS ratio suggests a significant
correlation with each other, also with HOMA-IR, and TyG index value. Hence, we suggest
beneficial risk assessment ratios in type 2 diabetes insulin resistance and its associated
cardiovascular diseases complications.
Keywords: Type 2 diabetes; Novel lipid, sugar ratio; TyG index; Insulin resistant,
Receiver operating characteristic curve Publication date: 01/12/2021 https://ijbpas.com/pdf/2021/December/MS_IJBPAS_2021_5780.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2021/10.12.5780